Final results fronts the phase I study expansion cohort of Dehio0932, an oral HSP90 inhibitor, in patients with solid tumors.

Affiliation auteurs!!!! Error affiliation !!!!
TitreFinal results fronts the phase I study expansion cohort of Dehio0932, an oral HSP90 inhibitor, in patients with solid tumors.
Type de publicationJournal Article
Year of Publication2014
AuteursFumoleau P, Soria J-C, Delord J-P, Belli R, Brienza S, Zanna C, Destaillats A, Rouits E, Hollebecque A, Gazzah A, Isambert N
JournalJOURNAL OF CLINICAL ONCOLOGY
Volume32
Date PublishedMAY 20
Type of ArticleMeeting Abstract
ISSN0732-183X
DOI10.1200/jco.2014.32.15_suppl.2550